We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Safety Alerts on Botox, Hospira and Potiga
FDA Issues Safety Alerts on Botox, Hospira and Potiga
May 3, 2013
Over the past two weeks, the FDA has issued a flurry of safety alerts to warn the public of problems with different drugs, including adverse events tied to the anti-seizure drug Potiga, fake Botox and fleck-infused containers of injectable drugs produced by Hospira.